BSG and acute myocardial infarction: To our knowledge, we were pioneers in using specific EMMPRIN-binding peptides in preclinical animal models of acute myocardial infarction, since they were tested in 293 cells [29], THP-1 cells [30], and in peripheral blood monocyte cell cultures [31].